SCHEMBL2656101

SCHEMBL2656101

C[N+]1(C)CCNC1c1cccs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTR2A P28223 3/20 0.35
HTR2C P28335 3/20 0.35
MAPT P10636 5/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 3/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HTT P42858 2/20 0.32
TSHR P16473 1/20 0.32
GAA P10253 2/20 0.31
POLB P06746 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4428525 0.71 SLC6A2 (0.38) HTR2CSLC6A2SLC6A3CYP1A2CYP2C19
SCHEMBL9693463 0.67 KDM4E (0.47) ALDH1A1MEN1KMT2AHTR2AHTR2C
SCHEMBL18998453 0.63
SCHEMBL6179170 0.63 CHRM5 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2POLB
SCHEMBL20292058 0.63 CHRM5 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2POLB
SCHEMBL166764 0.63 CHRM5 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2POLB
SCHEMBL27551235 0.62 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL5467244 0.62 SLC18A3 (0.48) ALDH1A1MEN1KMT2AHTR2CMAPT
SCHEMBL517623 0.62 MAPT (0.46) ALDH1A1MEN1KMT2AHTR2AHTR2C
SCHEMBL7008410 0.62 MEN1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185570-A2 NOVEL ACTIVATORS OF GLUCOKINASE Metabasis Therapeutics, Inc. (US) 2010-05-19 EP disclosed
WO-2009023718-A2 NOVEL ACTIVATORS OF GLUCOKINASE METABASIS THERAPEUTICS, INC. (US) 2009-02-19 WO disclosed
EP-1086098-A1 THIENYL SUBSTITUTED ACYLGUANIDINES AS INHIBITORS OF BONE RESORPTION AND VITRONECTIN RECEPTOR ANTAGONISTS Aventis Pharma Deutschland GmbH (DE) 2001-03-28 EP disclosed
WO-1999059992-A1 THIENYL SUBSTITUTED ACYLGUANIDINES AS INHIBITORS OF BONE RESORPTION AND VITRONECTIN RECEPTOR ANTAGONISTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-11-25 WO disclosed